An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma ; volume:24 ; number:1 ; day:7 ; month:12 ; year:2023 ; pages:1-12 ; date:12.2023
Respiratory research ; 24, Heft 1 (7.12.2023), 1-12, 12.2023
- Urheber
-
El-Husseini, Zaid W.
Khalenkow, Dmitry
Lan, Andy
Molen, Thys van der
Brightling, Chris
Papi, Alberto
Rabe, Klaus F.
Siddiqui, Salman
Singh, Dave
Kraft, Monica
Beghe, Bianca
Berge, Maarten van den
Gosliga, Djoke van
Nawijn, Martijn C.
Rose-John, Stefan
Koppelman, Gerard H.
Gosens, Reinoud
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-023-02617-w
- URN
-
urn:nbn:de:101:1-2024022308063846673999
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- El-Husseini, Zaid W.
- Khalenkow, Dmitry
- Lan, Andy
- Molen, Thys van der
- Brightling, Chris
- Papi, Alberto
- Rabe, Klaus F.
- Siddiqui, Salman
- Singh, Dave
- Kraft, Monica
- Beghe, Bianca
- Berge, Maarten van den
- Gosliga, Djoke van
- Nawijn, Martijn C.
- Rose-John, Stefan
- Koppelman, Gerard H.
- Gosens, Reinoud
- SpringerLink (Online service)
Ähnliche Objekte (12)
Instrumented gait analysis defines the walking signature of CACNA1A disorders
Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
Transcriptional profiling of Arabidopsis root hairs and pollen defines an apical cell growth signature
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Subgroup growth
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Robust subgroup discovery : Discovering subgroup lists using MDL
BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8+ T cell infiltration in colorectal cancer
Instrumented gait analysis defines the walking signature of CACNA1A disorders
Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
Transcriptional profiling of Arabidopsis root hairs and pollen defines an apical cell growth signature
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Subgroup growth
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Robust subgroup discovery : Discovering subgroup lists using MDL
BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8+ T cell infiltration in colorectal cancer
Instrumented gait analysis defines the walking signature of CACNA1A disorders
Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
Transcriptional profiling of Arabidopsis root hairs and pollen defines an apical cell growth signature
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Subgroup growth
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Robust subgroup discovery : Discovering subgroup lists using MDL